Giulia C. Kennedy - Sep 7, 2021 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jane Alley as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Sep 7, 2021
Transactions value $
-$470,045
Form type
4
Date filed
9/9/2021, 05:07 PM
Previous filing
Sep 7, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Options Exercise $26.3K +4.41K +8.64% $5.98 55.4K Sep 7, 2021 Direct F1
transaction VCYT Common Stock Options Exercise $75.8K +3.75K +6.77% $20.21 59.1K Sep 7, 2021 Direct F1
transaction VCYT Common Stock Options Exercise $108K +4.38K +7.4% $24.69 63.5K Sep 7, 2021 Direct F1
transaction VCYT Common Stock Sale -$608K -12K -18.95% $50.52 51.5K Sep 7, 2021 Direct F1, F2
transaction VCYT Common Stock Sale -$25.5K -497 -0.97% $51.23 51K Sep 7, 2021 Direct F1, F3
transaction VCYT Common Stock Sale -$46.8K -926 -1.82% $50.53 50K Sep 8, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Options Exercise $0 -4.41K -33.33% $0.00 8.81K Sep 7, 2021 Common Stock 4.41K $5.98 Direct F1, F4
transaction VCYT Stock Option (right to buy) Options Exercise $0 -3.75K -14.29% $0.00 22.5K Sep 7, 2021 Common Stock 3.75K $20.21 Direct F1, F5
transaction VCYT Stock Option (right to buy) Options Exercise $0 -4.38K -9.09% $0.00 43.8K Sep 7, 2021 Common Stock 4.38K $24.69 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
F2 Represents weighted average sales price. Sale prices for the transactions range from $50.06 to $51.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3 Represents weighted average sales price. Sale prices for the transactions range from $51.07 to $51.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4 The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F5 The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6 The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.